Abigail Aning is a Principal Research Assistant at the Department of Clinical Pathology, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana. With extensive experience in pharmacology, toxicology, and biochemical research, her work focuses on understanding how natural and synthetic therapeutic agents interact with human metabolic systems. She is particularly interested in Cytochrome P450 drug-metabolizing enzymes, drug–drug and herb–drug interactions, and the discovery of bioactive compounds from natural products. Her research explores the cytotoxic, anticancer, antiplasmodial, and antioxidant properties of Ghanaian medicinal plants, contributing to efforts to identify new therapeutic candidates for cancer, infectious diseases, and oxidative stress–related disorders. She has participated in several multidisciplinary projects, including cytotoxicity screening of anti-COVID-19 compounds, in vitro assessment of plant extracts, and mechanistic studies examining how xenobiotics influence metabolic enzyme pathways. Her work combines in vitro assays with in silico approaches to investigate drug action, toxicity, and molecular mechanisms.
Abigail Aning is a Principal Research Assistant at the Department of Clinical Pathology, Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana. With extensive experience in pharmacology, toxicology, and biochemical research, her work focuses on understanding how natural and synthetic therapeutic agents interact with human metabolic systems. She is particularly interested in Cytochrome P450 drug-metabolizing enzymes, drug–drug and herb–drug interactions, and the discovery of bioactive compounds from natural products. Her research explores the cytotoxic, anticancer, antiplasmodial, and antioxidant properties of Ghanaian medicinal plants, contributing to efforts to identify new therapeutic candidates for cancer, infectious diseases, and oxidative stress–related disorders. She has participated in several multidisciplinary projects, including cytotoxicity screening of anti-COVID-19 compounds, in vitro assessment of plant extracts, and mechanistic studies examining how xenobiotics influence metabolic enzyme pathways. Her work combines in vitro assays with in silico approaches to investigate drug action, toxicity, and molecular mechanisms.